Verrica (VRCA) director Diem Nguyen awarded 16,000 stock options at $6.04

Rhea-AI Filing Summary

Verrica Pharmaceuticals Inc. director Diem Nguyen received a grant of stock options covering 16,000 shares of common stock. The options have an exercise price of $6.04 per share and expire on June 4, 2036.

These options were granted as compensation and vest in 12 equal monthly installments beginning on July 5, 2026. They will in any event be fully vested on the date of the next annual meeting of stockholders, subject to Nguyen’s continued service as a director through each vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nguyen Diem

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	16,000	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 16,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 16,000 options Exercise price: $6.04 per share Expiration date: June 4, 2036 +3 more

6 metrics

Options granted 16,000 options Stock option grant to director Diem Nguyen

Exercise price $6.04 per share Strike price for the 16,000 stock options

Expiration date June 4, 2036 Option term end for granted options

Underlying shares 16,000 shares Common stock underlying the options

Vesting start July 5, 2026 First monthly vesting date for options

Vesting pattern 12 equal monthly installments Schedule for option vesting

Key Terms

Stock Option (right to buy), exercise price, vesting, expiration date, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

exercise price financial

"conversion_or_exercise_price: "6.0400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"shares underlying this option shall vest and become exercisable in 12 equal monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"expiration_date: "2036-06-04T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nguyen Diem

(Last) (First) (Middle)

C/O VERRICA PHARMACEUTICALS INC.

44 WEST GAY STREET, SUITE 400

(Street)

WEST CHESTER PENNSYLVANIA 19380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Verrica Pharmaceuticals Inc. [ VRCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$6.04	06/05/2026		A		16,000		(1)	06/04/2036	Common Stock	16,000	$0	16,000	D

Explanation of Responses:

1. The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

	/s/ Diem Nguyen	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Verrica Pharmaceuticals (VRCA) director Diem Nguyen report in this Form 4?

Diem Nguyen reported receiving a grant of stock options for 16,000 shares of Verrica Pharmaceuticals common stock. The grant is a compensation award, not an open-market purchase, and reflects additional incentive-based exposure to the company’s equity over time.

What are the key terms of Diem Nguyen’s Verrica Pharmaceuticals (VRCA) stock options?

The reported stock options cover 16,000 shares with an exercise price of $6.04 per share and an expiration date of June 4, 2036. These terms define the cost to exercise the options and the last date they can be used.

How do the Verrica Pharmaceuticals (VRCA) options granted to Diem Nguyen vest?

The options vest in 12 equal monthly installments starting July 5, 2026, and will be fully vested by the next annual meeting of stockholders. Vesting is conditioned on Nguyen’s continued service as a director through each applicable vesting date.

Is Diem Nguyen’s Verrica Pharmaceuticals (VRCA) Form 4 transaction a market buy or sell?

The Form 4 shows a grant or award acquisition of stock options, coded as an “A” transaction. It is a compensation-related award, not an open-market purchase or sale of Verrica Pharmaceuticals common stock in the public market.

How many Verrica Pharmaceuticals (VRCA) derivative securities does Diem Nguyen hold after this grant?

After the reported transaction, Nguyen holds 16,000 stock options related to Verrica Pharmaceuticals common stock. These options represent the right to buy 16,000 shares at $6.04 per share, subject to the vesting schedule and the June 4, 2036 expiration date.